CVS Health (NYSE:CVS – Get Free Report) and Billiontoone (NASDAQ:BLLN – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation.
Earnings and Valuation
This table compares CVS Health and Billiontoone”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CVS Health | $402.07 billion | 0.28 | $1.77 billion | $8.59 | 10.30 |
| Billiontoone | $436.87 million | 10.53 | $7.45 million | $0.92 | 104.68 |
CVS Health has higher revenue and earnings than Billiontoone. CVS Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares CVS Health and Billiontoone’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CVS Health | 2.62% | 13.65% | 4.20% |
| Billiontoone | 10.95% | 9.16% | 6.78% |
Insider & Institutional Ownership
80.7% of CVS Health shares are owned by institutional investors. 0.9% of CVS Health shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for CVS Health and Billiontoone, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CVS Health | 0 | 2 | 23 | 0 | 2.92 |
| Billiontoone | 1 | 3 | 7 | 0 | 2.55 |
CVS Health currently has a consensus target price of $107.33, indicating a potential upside of 21.29%. Billiontoone has a consensus target price of $124.38, indicating a potential upside of 29.14%. Given Billiontoone’s higher possible upside, analysts plainly believe Billiontoone is more favorable than CVS Health.
Summary
CVS Health beats Billiontoone on 7 of the 13 factors compared between the two stocks.
About CVS Health
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
About Billiontoone
BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
